Comprehensive genomic signature of pyroptosis-related genes and relevant characterization in hepatocellular carcinoma

Background Currently, the most predominant type of liver cancer is hepatocellular carcinoma (HCC), which is also the fourth leading cause of cancer-related death in the global population. Pyroptosis is an emerging form of cell death that affects the prognosis of cancer patients by modulating tumor c...

Full description

Bibliographic Details
Main Authors: Sheng Wang, Songsen Gao, Liang Shan, Xueyi Qian, Jiajie Luan, Xiongwen Lv
Format: Article
Language:English
Published: PeerJ Inc. 2023-01-01
Series:PeerJ
Subjects:
Online Access:https://peerj.com/articles/14691.pdf
_version_ 1797423983882141696
author Sheng Wang
Songsen Gao
Liang Shan
Xueyi Qian
Jiajie Luan
Xiongwen Lv
author_facet Sheng Wang
Songsen Gao
Liang Shan
Xueyi Qian
Jiajie Luan
Xiongwen Lv
author_sort Sheng Wang
collection DOAJ
description Background Currently, the most predominant type of liver cancer is hepatocellular carcinoma (HCC), which is also the fourth leading cause of cancer-related death in the global population. Pyroptosis is an emerging form of cell death that affects the prognosis of cancer patients by modulating tumor cell migration, proliferation and invasion. However, the evaluation of pyroptosis in the prognosis of HCC is still insufficient. Methods A total of 365 HCC patients from the TCGA-LIHC cohort were classified into two distinct subtypes using consensus clustering of pyroptosis-related genes (PRGs). Following univariate Cox analysis of differentially expressed genes between subtypes, we established a prognostic model (PRGs-score, PRGS) by LASSO Cox analysis. We further tested the predictive power of the prognostic model in the ICGC (LIRI-JP) and GEO (GSE14520) cohorts. The tumor microenvironment (TME) was studied using the CIBERSORT. The enrichment scores for immune cells and immune functions in low- and high-PRGS groups were assessed using ssGSEA. The IMvigor210 cohort was used to investigate the immunotherapy efficacy. Furthermore, we validated the expression of prognostic genes in PRGS by RT-qPCR in vitro. Results The subtyping of HCC based on PRGs exhibited distinct clinical characteristics. We developed a prognostic model PRGS by differentially expressed genes between different subtypes. The results showed that PRGS could well forecast the survival of HCC patients in different cohorts and was associated with the immune microenvironment. Moreover, PRGS was considered to be an independent prognostic risk factor and superior to other pyroptosis-related signatures. Low-PRGS implied greater immune cell infiltration and better overall survival with immunotherapy. The results of RT-qPCR also showed that prognostic genes were significantly dysregulated in HCC. Conclusions PRGS has promising application in forecasting the prognosis of HCC patients, and its relationship with the immune microenvironment provides a basis for the subsequent treatment and research of HCC.
first_indexed 2024-03-09T07:55:46Z
format Article
id doaj.art-8521462baf0c4656966f52933c4bd7bf
institution Directory Open Access Journal
issn 2167-8359
language English
last_indexed 2024-03-09T07:55:46Z
publishDate 2023-01-01
publisher PeerJ Inc.
record_format Article
series PeerJ
spelling doaj.art-8521462baf0c4656966f52933c4bd7bf2023-12-03T01:05:10ZengPeerJ Inc.PeerJ2167-83592023-01-0111e1469110.7717/peerj.14691Comprehensive genomic signature of pyroptosis-related genes and relevant characterization in hepatocellular carcinomaSheng Wang0Songsen Gao1Liang Shan2Xueyi Qian3Jiajie Luan4Xiongwen Lv5Department of Pharmacy, The First Affiliated Hospital of Wannan Medical College (Yijishan Hospital of Wannan Medical College), Wuhu, Anhui, ChinaDepartment of Orthopedics (Spinal Surgery), The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, ChinaThe Key Laboratory of Anti-Inflammatory and Immune Medicines, Ministry of Education, Anhui Province Key Laboratory of Major Autoimmune Diseases, School of Pharmacy, Institute for Liver Disease, Anhui Medical University, Hefei, Anhui, ChinaDepartment of Pharmacy, The First Affiliated Hospital of Wannan Medical College (Yijishan Hospital of Wannan Medical College), Wuhu, Anhui, ChinaDepartment of Pharmacy, The First Affiliated Hospital of Wannan Medical College (Yijishan Hospital of Wannan Medical College), Wuhu, Anhui, ChinaThe Key Laboratory of Anti-Inflammatory and Immune Medicines, Ministry of Education, Anhui Province Key Laboratory of Major Autoimmune Diseases, School of Pharmacy, Institute for Liver Disease, Anhui Medical University, Hefei, Anhui, ChinaBackground Currently, the most predominant type of liver cancer is hepatocellular carcinoma (HCC), which is also the fourth leading cause of cancer-related death in the global population. Pyroptosis is an emerging form of cell death that affects the prognosis of cancer patients by modulating tumor cell migration, proliferation and invasion. However, the evaluation of pyroptosis in the prognosis of HCC is still insufficient. Methods A total of 365 HCC patients from the TCGA-LIHC cohort were classified into two distinct subtypes using consensus clustering of pyroptosis-related genes (PRGs). Following univariate Cox analysis of differentially expressed genes between subtypes, we established a prognostic model (PRGs-score, PRGS) by LASSO Cox analysis. We further tested the predictive power of the prognostic model in the ICGC (LIRI-JP) and GEO (GSE14520) cohorts. The tumor microenvironment (TME) was studied using the CIBERSORT. The enrichment scores for immune cells and immune functions in low- and high-PRGS groups were assessed using ssGSEA. The IMvigor210 cohort was used to investigate the immunotherapy efficacy. Furthermore, we validated the expression of prognostic genes in PRGS by RT-qPCR in vitro. Results The subtyping of HCC based on PRGs exhibited distinct clinical characteristics. We developed a prognostic model PRGS by differentially expressed genes between different subtypes. The results showed that PRGS could well forecast the survival of HCC patients in different cohorts and was associated with the immune microenvironment. Moreover, PRGS was considered to be an independent prognostic risk factor and superior to other pyroptosis-related signatures. Low-PRGS implied greater immune cell infiltration and better overall survival with immunotherapy. The results of RT-qPCR also showed that prognostic genes were significantly dysregulated in HCC. Conclusions PRGS has promising application in forecasting the prognosis of HCC patients, and its relationship with the immune microenvironment provides a basis for the subsequent treatment and research of HCC.https://peerj.com/articles/14691.pdfHepatocellular carcinomaPyroptosisPrognosisImmune microenvironmentImmunotherapy
spellingShingle Sheng Wang
Songsen Gao
Liang Shan
Xueyi Qian
Jiajie Luan
Xiongwen Lv
Comprehensive genomic signature of pyroptosis-related genes and relevant characterization in hepatocellular carcinoma
PeerJ
Hepatocellular carcinoma
Pyroptosis
Prognosis
Immune microenvironment
Immunotherapy
title Comprehensive genomic signature of pyroptosis-related genes and relevant characterization in hepatocellular carcinoma
title_full Comprehensive genomic signature of pyroptosis-related genes and relevant characterization in hepatocellular carcinoma
title_fullStr Comprehensive genomic signature of pyroptosis-related genes and relevant characterization in hepatocellular carcinoma
title_full_unstemmed Comprehensive genomic signature of pyroptosis-related genes and relevant characterization in hepatocellular carcinoma
title_short Comprehensive genomic signature of pyroptosis-related genes and relevant characterization in hepatocellular carcinoma
title_sort comprehensive genomic signature of pyroptosis related genes and relevant characterization in hepatocellular carcinoma
topic Hepatocellular carcinoma
Pyroptosis
Prognosis
Immune microenvironment
Immunotherapy
url https://peerj.com/articles/14691.pdf
work_keys_str_mv AT shengwang comprehensivegenomicsignatureofpyroptosisrelatedgenesandrelevantcharacterizationinhepatocellularcarcinoma
AT songsengao comprehensivegenomicsignatureofpyroptosisrelatedgenesandrelevantcharacterizationinhepatocellularcarcinoma
AT liangshan comprehensivegenomicsignatureofpyroptosisrelatedgenesandrelevantcharacterizationinhepatocellularcarcinoma
AT xueyiqian comprehensivegenomicsignatureofpyroptosisrelatedgenesandrelevantcharacterizationinhepatocellularcarcinoma
AT jiajieluan comprehensivegenomicsignatureofpyroptosisrelatedgenesandrelevantcharacterizationinhepatocellularcarcinoma
AT xiongwenlv comprehensivegenomicsignatureofpyroptosisrelatedgenesandrelevantcharacterizationinhepatocellularcarcinoma